All lobbying filings

TARPLIN, DOWNS & YOUNG, LLC

TARPLIN, DOWNS & YOUNG, LLC filed a Q3 termination report for HANSA BIOPHARMA on October 20, 2026, reporting $60,000 in lobbying income.

Lobbying for HANSA BIOPHARMA · Biopharmaceutical company

All filings by TARPLIN, DOWNS & YOUNG, LLC · Everything HANSA BIOPHARMA has reported

Filing · LD-2 quarterly report Q3 termination

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$60,000

What the client paid this registrant for the period.

Representation ended

Aug 31, 2026

The registrant reported terminating its work for this client.

Official filing document

Lobbyists on this filing 5

JENNIFER B YOUNG

Previously held: Asst. Sec. for Leg.- HHS; Dep. Asst. Sec for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff. Sen. Cmte. on Finance
CHARLOTTE SPEARS IVANCIC

Previously held: Leg. Counsel, Sen. Jim DeMint; Health Counsel, Maj. Leader Bill Frist; Counsel and Budget Analyst, House Budget Cmte.; Asst. to the Speaker for Policy, Speaker John Boehner
PAMELA SMITH

Previously held: Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Sen. HELP Cmte.; Staff Dir., Sen. HELP Cmte.; Counsel to Asst. AG, Civil Div., Dept. of Justice; Spec. Counsel, Ofc of Leg. Affairs, Dept. of Justice; Counsel and LA, Sen. Carol Moseley-Braun
PARICK BRAERTON CARROLL

Previously held: Leg Asst. Rep. Ray LaHood, Leg Dir. Rep. Kevin Yoder, PSM Senate Appropriations Cmte.
JEFF RECZEK New on this filing

Previously held: Dir. CDC Washington, Professional Staff Sen. Appropriations Cmte, Program Examiner OMB, Program Analyst Dept. of Transportation

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Kidney issues, access to innovation, rare disease issues, organ rejection

Budget/Appropriations

Federal budget issues

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.